businesspress24.com - SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celladon Corporation of Penden
 

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celladon Corporation of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2015 - CLDN

ID: 1372840

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 07/16/15 -- The following statement is being issued by Levi & Korsinsky, LLP:

or otherwise acquired securities of Celladon Corporation ("Celladon") (NASDAQ: CLDN) .

that a securities class action lawsuit has been commenced in the USDC for the Southern District of California. If you purchased or otherwise acquired Celladon Corporation securities between July 7, 2014 and June 25, 2015, . To get more information :



or contact Joseph E. Levi, Esq. either via email at or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

The complaint alleges that during the Class Period defendants'' made false and misleading statements and/or failed to disclose adverse information regarding the Company''s prospects for its lead drug candidate, MYDICAR, for treating enzyme deficiency in heart failure patients that results in inadequate pumping of the heart.

On April 26, 2015, Celladon announced that the Company''s Phase 2b CUPID2 trial of MYDICAR did not meet its primary and secondary goals. Then on June 1, 2015, Celladon issued a press release announcing the abrupt resignation of the Company''s Chief Executive Officer. Then, on June 26, 2015, Celladon announced the suspension of its plans for further research or development of its MYDICAR program and other pre-clinical programs, indicating there was a possibility that the Company could be liquidated with net cash available to shareholders of $25-$30 million.

to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn''t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm''s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.







CONTACT:
Levi & Korsinsky, LLP
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of CorMedix, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 4, 2015 -- CRMD
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Avalanche Biotechnologies, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of September 8, 2015 -- AAVL
Bereitgestellt von Benutzer: Marketwired
Datum: 16.07.2015 - 12:01 Uhr
Sprache: Deutsch
News-ID 1372840
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Legal


Anmerkungen:


Diese Pressemitteilung wurde bisher 205 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Celladon Corporation of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 31, 2015 - CLDN
"
steht unter der journalistisch-redaktionellen Verantwortung von

Levi & Korsinsky, LLP (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Levi & Korsinsky, LLP



 

Who is online

All members: 10 572
Register today: 2
Register yesterday: 0
Members online: 0
Guests online: 153


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.